ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
33 hedge funds and large institutions have $1.91M invested in Acorda Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
33
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$9K | |
| 2 | +$200 | |
| 3 | +$181 | |
| 4 |
Two Sigma Advisers
New York
|
+$108 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$18 |
Top Sellers
| 1 | -$36.3K | |
| 2 | -$34.7K | |
| 3 | -$18K | |
| 4 |
Renaissance Technologies
New York
|
-$13.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.53K |